Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders

US Patent 10561617 · Granted Feb 18, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified release composition of orlistat and acarbose for the treatment of obesi2024
Modified release composition of orlistat and acarbose for the treatment of obesi2024
Modified release composition of orlistat and acarbose for the treatment of obesi2024
Modified release composition of orlistat and acarbose for the treatment of obesi2024
Modified release composition of orlistat and acarbose for the treatment of obesi2024
Pharmaceutical compositions for glucocorticoid replacement therapy2020
Pharmaceutical compositions for acute glucocorticoid therapy2018
Use of carboxymethylcellulose to control ejectability and solidification time of2015
Composition comprising biodegradable hydrating ceramics for controlled drug deli2015
Bioresorbable controlled-release composition2015
Method for treating prostate diseases based on local delivery of active substanc2015
Injector device2013